World-first type 1 diabetes risk screening study in adults opens for recruitment

A world-first research programme led by the University of Bristol that will identify adults at high risk of developing type 1 diabetes opens for recruitment.

Thyroid Drug & Bone Loss; GLP-1s’ Renal Benefit; Menopause Musculoskeletal Syndrome

The thyroid medication levothyroxine may be associated with bone loss, according to a study that will be presented at the Radiological Society of North America’s

November 27, 2024

New insights into dendritic cell biology could lead to improved cancer therapies

The cells of the immune system circulate mainly in the blood and migrate into the body’s tissues after an inflammation. Some types of immune cells,

July 17, 2023

IAP-0971 by Sunho (China) Biopharmaceutical for Liver Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.